Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US15754934Application Date: 2016-08-24
-
Publication No.: US10406146B2Publication Date: 2019-09-10
- Inventor: Akira Kaieda , Naoki Ishii , Hiroshi Nara , Masato Yoshikawa , Masaki Daini
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2015-165921 20150825
- International Application: PCT/JP2016/074573 WO 20160824
- International Announcement: WO2017/033946 WO 20170302
- Main IPC: C07D413/14
- IPC: C07D413/14 ; A61K31/454 ; A61K31/4545 ; A61K31/5377 ; C07D413/12 ; C07D417/14 ; C07D471/04 ; A61P29/00
Abstract:
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound.The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20180263967A1 HETEROCYCLIC COMPOUND Public/Granted day:2018-09-20
Information query
